At the same time Enhancing primary mical service capabilities, and promoting the construction of regional mical
alliances and regional mical centers have become the core directions of the new round of mical reform.
In this context, Capital Mical University Clinical Laboratory Center, as an independent legal entity
directly under the Capital Mical University, is also industry email list the only municipal public nonprofit mical institution
in Beijing that focuses on providing testing and pathological diagnosis services. When it adds a new site
in the Capital Mical University Science and Technology Park in Beijing Daxing Biomicine Industry
Base, it chooses to join hands with Aidikang, a leader in the industry, to jointly build and create the
Capital Regional Mical Testing Center. This is undoubtly a farreaching “strong alliance” that
demonstrates the farreaching layout and forwardlooking vision of both parties in the mical field.
On the one hand, the cooperation between the two parties will achieve
Deep integration at the technology and service levels, and drive the highquality development of discipline construction .
It is not difficult to see from the macrostrategic planning of the development of Capital Mical
University and the overall layout of the construction of Capital Mical University Science and
Technology Park that the establishment and business process development of the Capital Regional Mical Testing
Center, an important platform, is of vital importance. It is not only committ to the transformation of
results of innovative diagnostic technologies, but also shoulders the mission of driving the discipline
construction of Capital Mical University to a new level. Strengthening the collaborative cooperation
between micine, industry, academia and research, and accelerating the clinical application of
innovative diagnostic technologies are key measures to improve the quality of mical services in my country.
As one of the three largest ICL service providers in China
Aidikang has a wealth of testing projects and a complete service system. It relies on three major
service platforms: R&D center, drug clinical, and testing services, more than 4,000 testing projects, a
strong logistics network covering 30 philippines numbers provinces, autonomous regions, and municipalities across the
country, and an advanc management system of independent laboratories with crossregional chain operations to achieve largescale testing to ruce costs and improve efficiency At the same time.